Navigation Links
BioSpecifics Technologies Corp. Announces Positive Data from Phase 2a Study of CCH for Treatment of Cellulite
Date:8/21/2014

LYNBROOK, N.Y., Aug. 21, 2014 /PRNewswire/ -- BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company developing first in class collagenase-based products marketed as XIAFLEX® (collagenase clostridium histolyticum or CCH) in the U.S. and XIAPEX® in the EU, today announced positive, statistically significant results from a randomized, double-blind Phase 2a study of CCH for the potential treatment of cellulite, or edematous fibrosclerotic panniculopathy. The results showed that all three doses of CCH used in the study, including a low, medium and high dose, demonstrated an improvement in the appearance of cellulite as measured by the trial endpoints of physician and patient-assessed improvements. CCH was well-tolerated by all dose groups with most adverse events being mild to moderate and primarily limited to the local injection area.

"These positive results are very encouraging, particularly because both patients and physicians saw a statistically significant improvement in the appearance of cellulite after CCH treatment," commented Thomas L. Wegman, President of BioSpecifics. "The market for cellulite treatment is large, which makes these data very exciting for the prospective commercial success of CCH in this indication. The results also position CCH as a potential treatment for other aesthetic needs, so we are eager to see continued progress by Auxilium in initiating a subsequent Phase 2b trial of CCH in cellulite in the second quarter of 2015."

The Phase 2a study was conducted by BioSpecifics' strategic partner Auxilium Pharmaceuticals, Inc. (Auxilium) and enrolled 150 women between the ages of 18 and 45 in the U.S. Each subject received up to three treatment sessions of drug or placebo according to randomization (5 high-dose (0.84mg): 5 mid (0.48mg): 5 l
'/>"/>

SOURCE BioSpecifics Technologies Corp.
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. BioSpecifics Technologies Corp. Announces Appointment of George Gould to Board of Directors
2. BioSpecifics Technologies Corp. Announces Presentations at Two Upcoming Investor Conferences in March
3. BioSpecifics Technologies Corp. Reports Second Quarter 2012 Financial Results
4. BioSpecifics Technologies Corp. To Present at UBS Global Life Sciences Conference
5. BioSpecifics Technologies Corp. Reports Third Quarter 2012 Financial Results
6. BioSpecifics Technologies Corp. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
7. BioSpecifics Technologies Corp. Announces Partnership between Auxilium and Swedish Orphan Biovitrum AB for XIAPEX in Eurasia and Africa
8. BioSpecifics Technologies Corp. to Host Conference Call to Report Third Quarter 2013 Financial Results on Tuesday, November 12, 2013
9. BioSpecifics Technologies Corp. Announces Top-line Data from Phase 2 Trial of CCH for Canine Lipoma
10. BioSpecifics Technologies Corp. Reports Second Quarter 2014 Financial Results
11. Palatin Technologies, Inc. to Report Fiscal Year 2012 First Quarter Results; Teleconference and Webcast to be held on November 15, 2011
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/15/2014)... , Nov. 14, 2014 Algenol Biofuels will present ... the Oceanographic Museum of Monaco . ... Monaco is an annual invitation-only event hosted by Innovator Capital, ... Other partners and sponsors include Prince Albert ... & Burling, Cranfield University, PR Newswire, the Monte-Carlo SBM, Oceanographic ...
(Date:11/15/2014)... Calif. , Nov. 14, 2014  F. ... by Continental Who,s Who as a Pinnacle Professional in ... role as President of Cell Point, LLC. ... offices in Centennial, Colorado , ... . The company,s five technology platforms, ethylenedicysteine drug ...
(Date:11/12/2014)... 12, 2014  ReachBio Research Labs (a registered trade ... ) announced today that it has signed an agreement ... ), giving Funakoshi non-exclusive distribution rights to ReachBio,s human ... market within Japan . Under a ... research services to Japanese drug development companies. ...
(Date:11/12/2014)... November 11, 2014 Innovative ... one year of achieving GMP compliance with InstantGMP™ ... defined and impressive blueprint for creating high quality ... Requisition process and ending with the final BPR ... each product is in the process,” explains Innovative ...
Breaking Biology Technology:Algenol Biofuels Selected to Present at CleanEquity Monaco 2015 2F. David Rollo, MD, Ph.D., FACC, FACNP is recognized by Continental Who's Who as a Pinnacle Professional 2Funakoshi to Distribute ReachBio Research Labs Human Primary Cell Products in Japan 2Funakoshi to Distribute ReachBio Research Labs Human Primary Cell Products in Japan 3Innovative Formulations Achieves GMP Compliance and Success with InstantGMP™ MES 2
... Food Industry Institute/L&P Food Ingredient Co. Ltd. (GDFII/L&P) today announced that ... the target date of its final decision in the sucralose case, ... dispute (docket# 337-TA-604) was filed against the company by its main ... ...
... A coalition of Indiana,s leaders in research, medicine, ... to launch Hoosiers Work for Health ( www.hoosiersworkforhealth.org ... innovation. Co-chairs, former Indianapolis Mayor Bart Peterson, ... Entertainment Jim Morris, kicked off the effort at ...
... deCODE genetics,Inc. (Nasdaq: DCGN ) today announced that it ... to be issued on Tuesday, March 31, after,the close of ... live webcast of,its conference call to discuss these results and ... Time/ 12pm GMT/1pm British,Summer Time. , ...
Cached Biology Technology:GDFII/L&P Confirms Target Date Extension Of U.S. ITC Sucralose Ruling 2Hoosiers Work for Health Highlights Impact of Medical Research and Innovation on Indiana Economy 2Hoosiers Work for Health Highlights Impact of Medical Research and Innovation on Indiana Economy 3Hoosiers Work for Health Highlights Impact of Medical Research and Innovation on Indiana Economy 4deCODE genetics Announces Webcast of Conference Call to Discuss Full-year 2008 Financial Results 2
(Date:11/7/2014)... CORAL SPRINGS, Florida , November 6, 2014 ... improved secure authentication for better mobile security revolutionizing online transactions. ... NXTD ), Alibaba Holdings Ltd. (NYSE: BABA ), ... MSFT ), eBay Inc. (NASDAQ: EBAY ... (NASDAQ: NXTD and NXTDW), a biometric authentication ...
(Date:11/6/2014)... - Insilico Medicine, Inc, a Baltimore-based bioinformatics company ... diseases announced a research collaboration with the international ... Inc (OTC: CSBR). , "There are many companies ... Champions Oncology,s TumorGraft technology is unique in a ... experimentally generating vast amounts of valuable data. Our ...
(Date:11/4/2014)... Nov. 5, 2014 – University of Utah engineers developed ... help jet fuel produce electricity without needing to ignite ... to power portable electronics, off-grid power and sensors. , ... in the American Chemical Society journal ACS Catalysis ... a chemical reaction between a fuel and an oxygen-rich ...
Breaking Biology News(10 mins):Universal Authentication Methods Provide More Secure Operations for Biometrics Devices - Company Joins FIDO Alliance for Consumer Protection 2Universal Authentication Methods Provide More Secure Operations for Biometrics Devices - Company Joins FIDO Alliance for Consumer Protection 3Universal Authentication Methods Provide More Secure Operations for Biometrics Devices - Company Joins FIDO Alliance for Consumer Protection 4Universal Authentication Methods Provide More Secure Operations for Biometrics Devices - Company Joins FIDO Alliance for Consumer Protection 5Universal Authentication Methods Provide More Secure Operations for Biometrics Devices - Company Joins FIDO Alliance for Consumer Protection 6Insilico Medicine, Inc announces research collaboration with Champions Oncology, Inc 2Jet-fueled electricity at room temperature 2
... because these animals are sensitive to changes in their ... mine" to give researchers early warnings about pollution or ... State University shows that data from the largest amphibian ... if uncorrected, could result in overestimates of frog populations. ...
... August 2nd, 2010 - Using little more than PVC rings, ... feel for soil water retention and field capacity, concepts that ... The demonstration, developed by Adam Howard, Drs. Josh Heitman ... to illustrate concepts that can be difficult for students to ...
... culturing adult human stem cells on a new type of ... about how the cells would differentiate, or what type of ... Aug. 1 edition of Nature Methods . Differentiation ... of cells. Understanding it is key to developing future stem ...
Cached Biology News:'Ribbit Radio' shows frog population estimates are likely flawed 2Students get a feel for soil-water relationships 2New insights into how stem cells determine what tissue to become 2
... polystyrene with frosted labeling surfaces, volume ... counting. 100% integrity tested. Linkage: This ... number, created to easily match Cornings ... yet, please order under the old ...
... clear polystyrene with frosted labeling surfaces, ... cell counting. 100% integrity tested. Linkage: ... product number, created to easily match ... availability yet, please order under the ...
Automated Cell Culture Flask...
... Bio-Plex suspension array system, 100-240 V, uses ... simultaneous quantitative analysis of up to 100 ... well. The suspension array is composed of ... of which may be conjugated with a ...
Biology Products: